Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 7, 2021; 27(41): 7041-7064
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7041
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7041
Rank | Title | Status | Results | Condition | Intervention | Location | URL |
1 | Fecal Microbiota Transplantation for the Treatment of Obesity | Completed | Available | Obesity | FMT vs placebo | United States | https://ClinicalTrials.gov/show/NCT02741518 |
2 | Faecal Microbiota Transplantation in Obesity | Recruiting | Not available | Obesity | FMT vs placebo | Finland | https://ClinicalTrials.gov/show/NCT03391817 |
3 | Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity | Enrolling by invitation | Not available | Obesity | FMT vs placebo | Norway | https://ClinicalTrials.gov/show/NCT03273855 |
4 | Fecal Microbiota Transplant (FMT) to Induce Weight Loss in Obese Subjects | Active, not recruiting | Not available | Obesity | FMT and mucosal microbiota assessment | China | https://ClinicalTrials.gov/show/NCT03789461 |
5 | FMT and Fiber in Patients With Metabolic Syndrome | Completed | Not available | Obesity, Metabolic Syndrome | FMT and dietary supplement with fiber (cellulose) vs placebo | Canada | https://ClinicalTrials.gov/show/NCT03727321 |
6 | Assessment of the Health Improvement of Obese Patients After Fecal Microbiota Transplantation (FMT) | Completed | Not available | Obesity, Type 1 and 2 Diabetes | FMT | Russian Federation | https://ClinicalTrials.gov/show/NCT04579263 |
7 | Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients | Unknown status | Not available | T2DM, Obesity | FMT and dietary intervention (high-fat low-fiber diet, sham diet or low-fat high-fiber diet) | Israel | https://ClinicalTrials.gov/show/NCT02346669 |
8 | Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome | Active, not recruiting | Not available | Obesity, Metabolic Syndrome | FMT and dietary supplement with fiber (cellulose) or FMT only vs placebo | Canada | https://ClinicalTrials.gov/show/NCT03477916 |
9 | Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM | Active, not recruiting | Not available | T2DM, Obesity | FMT and lifestyle modification program or FMT only vs placebo | China | https://ClinicalTrials.gov/show/NCT03127696 |
10 | Fecal Microbiota Transplant for Improvement of Metabolism | Completed | Available | Obesity | FMT vs placebo | United States | https://ClinicalTrials.gov/show/NCT02530385 |
11 | The Role of Microbiome in Recurrent Obesity | Not yet recruiting | Not available | Obesity | FMT vs placebo | Israel | https://ClinicalTrials.gov/show/NCT04697550 |
12 | Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver Disease | Recruiting | Not available | NAFLD | FMT, dietary intervention and physical activity vs placebo | India | https://ClinicalTrials.gov/show/NCT04594954 |
13 | Proposal to Examine the Effect of Fecal Transplantation on Obesity | Unknown status | Not available | Obesity | FMT vs placebo | Israel | https://ClinicalTrials.gov/show/NCT02336789 |
14 | Safety and Efficacy of Fecal Microbiota Transplantation | Recruiting | Not available | IBD, IBS, Obesity, Metabolic Syndrome, Infections, Others | FMT | China | https://ClinicalTrials.gov/show/NCT04014413 |
15 | Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD | Completed | Not available | Type 1 and 2 Diabetes, NAFLD, Obesity | FMT | Canada | https://ClinicalTrials.gov/show/NCT02496390 |
- Citation: Barone M, D'Amico F, Fabbrini M, Rampelli S, Brigidi P, Turroni S. Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives. World J Gastroenterol 2021; 27(41): 7041-7064
- URL: https://www.wjgnet.com/1007-9327/full/v27/i41/7041.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i41.7041